IQVIA Inc. completed the issuance and sale of €950,000,000 in gross proceeds of 4.625% senior notes due 2033. The net proceeds will be used to refinance existing indebtedness and cover offering-related fees and expenses. IQVIA Holdings Inc. is a provider of advanced analytics and clinical research services for the healthcare industry.
